ID   GM05658
AC   CVCL_7433
SY   GM5658; GM-05658
DR   CLO; CLO_0024607
DR   Coriell; GM05658
DR   Wikidata; Q54841909
RX   CelloPub=CLPUB00447;
RX   CelloPub=CLPUB00720;
RX   PubMed=2705456;
RX   PubMed=17668376;
RX   PubMed=24119401;
CC   Population: African American.
CC   Derived from site: In situ; Umbilical area, skin; UBERON=UBERON_8480053.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y3M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
RX   CelloPub=CLPUB00447;
RA   Mulivor R.A., Suchy S.F.;
RT   "1992/1993 catalog of cell lines. NIGMS human genetic mutant cell
RT   repository. 16th edition. October 1992.";
RL   (In) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda (1992).
//
RX   CelloPub=CLPUB00720;
RA   Greene A.E., Mulivor R.A.;
RT   "1986/1987 catalog of cell lines. NIGMS human genetic mutant cell
RT   repository. 13th edition. October 1986.";
RL   (In) Institute for Medical Research (Camden, N.J.) NIH 87-2011; pp.1-549; National Institutes of Health; Bethesda (1986).
//
RX   PubMed=2705456;
RA   Weiss M.J., Ray K., Fallon M.D., Whyte M.P., Fedde K.N.,
RA   Lafferty M.A., Mulivor R.A., Harris H.;
RT   "Analysis of liver/bone/kidney alkaline phosphatase mRNA, DNA, and
RT   enzymatic activity in cultured skin fibroblasts from 14 unrelated
RT   patients with severe hypophosphatasia.";
RL   Am. J. Hum. Genet. 44:686-694(1989).
//
RX   PubMed=17668376; DOI=10.1086/519248;
RA   Prandini P., Deutsch S., Lyle R., Gagnebin M., Delucinge-Vivier C.,
RA   Delorenzi M., Gehrig C., Descombes P., Sherman S.L.,
RA   Dagna-Bricarelli F., Baldo C., Novelli A., Dallapiccola B.,
RA   Antonarakis S.E.;
RT   "Natural gene-expression variation in Down syndrome modulates the
RT   outcome of gene-dosage imbalance.";
RL   Am. J. Hum. Genet. 81:252-263(2007).
//
RX   PubMed=24119401; DOI=10.1016/j.molcel.2013.09.009;
RA   Chen J.-Y., Lin J.-R., Tsai F.-C., Meyer T.;
RT   "Dosage of Dyrk1a shifts cells within a p21-cyclin D1 signaling map to
RT   control the decision to enter the cell cycle.";
RL   Mol. Cell 52:87-100(2013).
//